Clinical Study
The Incidence and Predictors of Thromboembolic Events in Patients with Lung Cancer
Table 4
Hemostatic factors “cut-offs” for venous thromboembolic events.
| | Any VTE | Serious VTE | | AUC (95% CI)1 | | Sensitivity | Specificity | Cutoff | AUC (95% CI)1 | | Sensitivity | Specificity | Cut Off |
| Platelets | 0.68 (0.63–0.74) |
<0.001
| 0.747 | 0.568 | 299.5 | 0.69 (0.63–0.75) |
<0.001
| 0.675 | 0.638 | 330.5 | WBC | 0.58 (0.52–0.63) |
0.017
| 0.560 | 0.602 | 6.36 | 0.57 (0.51–0.63) |
0.042
| 0.538 | 0.598 | 6.36 | Hemoglobin | 0.54 (0.48–0.61) | 0.180 | 0.582 | 0.463 | 123.5 | 0.54 (0.47–0.61) | 0.261 | 0.575 | 0.462 | 123.5 | PT | 0.51 (0.44–0.57) | 0.835 | 0.552 | 0.487 | 1.05 | 0.51 (0.44–0.58) | 0.751 | 0.566 | 0.488 | 1.05 | aPTT | 0.54 (0.48–0.61) | 0.194 | 0.517 | 0.597 | 35.95 | 0.55 (0.48–0.62) | 0.148 | 0.539 | 0.597 | 35.95 | Fibrinogen | 0.53 (0.46–0.60) | 0.435 | 0.573 | 0.532 | 3.15 | 0.53 (0.45–0.60) | 0.480 | 0.514 | 0.584 | 3.35 | D dimers | 0.56 (0.48–0.63) | 0.117 | 0.438 | 0.679 | 0.40 | 0.54 (0.46–0.63) | 0.249 | 0.492 | 0.592 | 0.38 |
|
|
ROC analysis.
|